The economic and political projections of the Economist Intelligence Unit (EIU) for 2021 onwards have revealed that coronavirus vaccines will not be available in amounts big enough to alter the game in the coming months.
Therefore, the EIU has confirmed that it holds its opinion that a vaccine will not begin to be broadly carried out in developing economies until mid-2021.
Initially, getting to the vaccine would be challenging when all developing countries are rushing to procure enough amounts and impoverished countries are struggling to receive funds, he said.
As a result, the roll-out will take even longer for middle-income and developing countries; we do not expect it to take place on a game-changing scale before 2022. For low-income nations, the picture seems much bleaker; we do not expect any of these states to have wide access to a vaccine before 2022-23, the EIU said.
Latest reports that some coronavirus vaccines are successful have not updated the economic and political projections of the Economist Intelligence Unit for 2021 onwards. Such declarations, while encouraging, reflect just the initial, small moves in the implementation of secure and successful immunisation programmes.
“In the coming months, vaccines will not be available in doses sufficient enough to be game-changing. Also, logistics and transportation would be tough. We therefore hold our opinion that, until mid-2021, a vaccine would not begin to be broadly carried out in developing economies.
“Initially, getting to the vaccine would be difficult, as all
Established nations are rushing to raise adequate sums and poorer countries are unable to secure support. As a result, it will take even longer to deploy in middle-income and developing countries; we do not expect it to take place on a game-changing scale before 2022.
For low-income nations, the picture looks much bleaker; most of these states are not expected to have wide access to vaccinations until 2022-23.
The chart illustrates our latest predictions for the global introduction of coronavirus vaccines, indicating when we plan the shots to be commonly accessible in – world for the general public (after priority or special groups have been vaccinated).